Also, IFNs can upregulate survival factors that protect cells against apoptotic stimuli, including MCL1, increased in myeloma presumably via STAT3 (88), and G1P3, which has been reported to promote tumor cell survival and contribute to poor outcome of patients in estrogen-receptor positive breast cancer (89). The gene discussed is STAT3; the disease is breast carcinoma.